GlaxoSmithKline S.A.E (EGX:BIOC)

Market Cap	5.46B +72.5%
Revenue (ttm)	3.73B +24.7%
Net Income	213.23M +22.6%
EPS	2.55 +22.6%
Shares Out	83.51M
PE Ratio	25.61
Forward PE	n/a
Dividend	1.00 (1.53%)
Ex-Dividend Date	Jan 12, 2026

Volume	59,753
Average Volume	89,310
Open	66.08
Previous Close	66.08
Day's Range	65.02 - 66.94
52-Week Range	34.34 - 81.50
Beta	0.76
RSI	59.54
Earnings Date	May 18, 2026

About GlaxoSmithKline S.A.E

GlaxoSmithKline S.A.E engages in production of pharmaceutical chemicals. The company is involved in manufacture of general and specialty medicines, and vaccines. GlaxoSmithKline S.A.E was founded in 1981 and is based in New Cairo, Egypt. GlaxoSmithKline S.A.E operates as a subsidiary of Glaxo Group Limited.

• Industry: Pharmaceutical Preparations
• Founded: 1981
• Employees: 800
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: BIOC

Financial Performance

In 2025, GlaxoSmithKline S.A.E's revenue was 3.73 billion, an increase of 24.73% compared to the previous year's 2.99 billion. Earnings were 213.23 million, an increase of 22.56%.